Advanced search
Show most relevant results first | Most recent results are first | Show use by person

Results 1-2 of 2 for narcolepsy segment:8633845

Written Answers — Department of Health: Medicinal Products (13 Jun 2023)

Peadar Tóibín: ...for Health further to Parliamentary Question No. 590 of 24 January 2023, if any price agreement has been reached between the HSE and a drug company (details supplied) for Sunosi in the treatment of narcolepsy or obstructive sleep apnoea; if so, if he will provide an update and indicate a timeframe when the drug will be available in Ireland; and if he will make a statement on the matter....

Written Answers — Department of Health: Medicinal Products (13 Jun 2023)

Stephen Donnelly: ...of Medical Goods) Act 2013. In October 2022, the HSE approved the drug SunosiĀ® (solriamfetol) for reimbursement under High Tech Arrangements subject to managed access for adult patients with narcolepsy (with or without cataplexy), in accordance with the proposed place in therapy as a second-line treatment. However, the company that holds the marketing authorisation for SunosiĀ®...

   Advanced search
Show most relevant results first | Most recent results are first | Show use by person